Annika Y. Claßen

ORCID: 0000-0003-2905-5139
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Neutropenia and Cancer Infections
  • COVID-19 Clinical Research Studies
  • Mycobacterium research and diagnosis
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Long-Term Effects of COVID-19
  • Fungal Infections and Studies
  • Antibiotic Resistance in Bacteria
  • Antibiotic Use and Resistance
  • Bacterial Identification and Susceptibility Testing
  • COVID-19 and healthcare impacts
  • Antifungal resistance and susceptibility
  • Healthcare cost, quality, practices
  • Bacteriophages and microbial interactions
  • Sepsis Diagnosis and Treatment
  • Surgical site infection prevention
  • Cytomegalovirus and herpesvirus research
  • Cardiac, Anesthesia and Surgical Outcomes
  • Patient Satisfaction in Healthcare
  • Blood disorders and treatments
  • Immunodeficiency and Autoimmune Disorders
  • Tuberculosis Research and Epidemiology
  • Inflammasome and immune disorders
  • Genomics and Phylogenetic Studies
  • Infectious Diseases and Mycology
  • Optical Imaging and Spectroscopy Techniques

University Hospital Cologne
2019-2025

University of Cologne
2019-2025

German Center for Infection Research
2019-2025

Heinrich Heine University Düsseldorf
2023-2025

Düsseldorf University Hospital
2023-2025

University of Michigan
2024

Instituto de Salud Carlos III
2024

Cologne Excellence Cluster on Cellular Stress Responses in Aging Associated Diseases
2024

Integrated Oncology (United States)
2024

Centrum für Integrierte Onkologie
2021-2023

Abstract Introduction Since the early SARS-CoV-2 pandemic, cancer patients have been assumed to be at higher risk for severe COVID-19. Here, we present an analysis of from LEOSS (Lean European Open Survey on Infected Patients) registry determine whether are risk. Patients and methods We retrospectively analyzed a cohort 435 2636 non-cancer with confirmed infection, enrolled between March 16 August 31, 2020. Data socio-demographics, comorbidities, cancer-related features infection course were...

10.1007/s00277-020-04328-4 article EN cc-by Annals of Hematology 2020-11-07

Abstract Purpose Knowledge regarding patients’ clinical condition at severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) detection is sparse. Data in the international, multicenter Lean European Open Survey on SARS-CoV-2-Infected Patients (LEOSS) cohort study may enhance understanding of COVID-19. Methods Sociodemographic and characteristics SARS-CoV-2-infected patients, enrolled LEOSS between March 16, 2020, May 14, were analyzed. Associations baseline stages diagnosis...

10.1007/s15010-020-01499-0 article EN cc-by Infection 2020-10-01

Hematologic and oncologic patients with chemo- or immunotherapy-related immunosuppression are at substantial risk for bacterial infections Pneumocystis jirovecii pneumonia (PcP). As resistances increasing worldwide new research reshapes our understanding of the interactions between human host commensals, administration antibacterial prophylaxis has become a matter discussion. This guideline constitutes an update 2013 published Infectious Diseases Working Party (AGIHO) German Society...

10.1007/s00277-021-04452-9 article EN cc-by Annals of Hematology 2021-04-13

Bacteriophage therapy holds promise in addressing the antibiotic-resistance crisis, globally and Germany. Here, we provide an overview of current situation (2023) applied phage supporting research The authors, interdisciplinary group working on patient-focused bacteriophage research, addressed production, banks, susceptibility testing, clinical application, ongoing translational regulatory situation, network structure They identified critical shortcomings including lack trials, a paucity...

10.3390/v15020588 article EN cc-by Viruses 2023-02-20

Abstract Background and purpose During acute coronavirus disease 2019 (COVID‐19) infection, neurological signs, symptoms complications occur. We aimed to assess their clinical relevance by evaluating real‐world data from a multinational registry. Methods analyzed COVID‐19 patients 127 centers, diagnosed between January 2020 February 2021, registered in the European LEOSS (Lean Open Survey on SARS‐Infected Patients) The effects of prior diseases effect outcome were studied using multivariate...

10.1111/ene.15072 article EN cc-by-nc-nd European Journal of Neurology 2021-08-19

Background. The management and outcomes of nontuberculous mycobacterial (NTM) infections in solid organ transplant (SOT) recipients are poorly characterized. We aimed to describe the 1-y mortality these patients. Methods. Retrospective, multinational, 1:2 matched case-control study included SOT aged 12 y old or older diagnosed with NTM infection between January 1, 2008, December 31, 2018. Controls were on transplanted organs, treatment center, posttransplant survival at least equal time...

10.1097/tp.0000000000005156 article EN Transplantation 2024-07-25

SARS-CoV-2 infection is associated with adverse outcomes in patients cardiovascular disease. Here, we analyzed whether specific biomarkers predict the clinical course of COVID-19 comorbidities.

10.1007/s00392-020-01769-9 article EN cc-by Clinical Research in Cardiology 2020-11-19

Abstract Purpose While more advanced COVID-19 necessitates medical interventions and hospitalization, patients with mild do not require this. Identifying at risk of progressing to might guide treatment decisions, particularly for better prioritizing in need hospitalization. Methods We developed a machine learning-based predictor deriving clinical score identifying asymptomatic/mild COVID-19. Clinical data from SARS-CoV-2 positive the multicenter Lean European Open Survey on Infected Patients...

10.1007/s15010-021-01656-z article EN cc-by Infection 2021-07-19

To determine the overall and procedure-specific incidence of surgical site infections (SSI) caused by Staphylococcus aureus (S. aureus) as well risk factors for such across all disciplines in Europe.This is a retrospective cohort patients with procedures performed at 14 European centres 2016, nested case-control analysis. S. SSI were identified semi-automated crossmatching bacteriological electronic health record data. Within each procedure, cases controls matched using optimal propensity...

10.1186/s13756-023-01309-w article EN cc-by Antimicrobial Resistance and Infection Control 2023-09-19

The Coronavirus Disease-2019 (COVID-19) pandemic has brought opportunities and challenges, especially for health services research based on routine data. In this article we will demonstrate by presenting lessons learned from establishing the currently largest registry in Germany providing a detailed clinical dataset Severe Acute Respiratory Syndrome 2 (SARS-CoV-2) infected patients: Lean European Open Survey SARS-CoV-2 Infected Patients (LEOSS).LEOSS is collaborative integrative approach...

10.1055/a-1655-8705 article DE Das Gesundheitswesen 2021-11-01

Coagulopathy and venous thromboembolism are common findings in coronavirus disease 2019 (COVID-19) associated with poor outcome. Timely initiation of anticoagulation after hospital admission was shown to be beneficial. In this study we aim examine the association pre-existing oral (OAC) outcome among a cohort SARS-CoV-2 infected patients.

10.1007/s00392-021-01939-3 article EN cc-by Clinical Research in Cardiology 2021-09-21

Abstract Background Risk factors for nontuberculous mycobacteria (NTM) infections after solid organ transplant (SOT) are not well characterized. Here we aimed to describe these factors. Methods Retrospective, multinational, 1:2 matched case-control study that included SOT recipients ≥12 years old diagnosed with NTM infection from 1 January 2008 31 December 2018. Controls were on transplanted organ, treatment center, and post-transplant survival greater than or equal the time diagnosis....

10.1093/cid/ciac608 article EN Clinical Infectious Diseases 2022-07-26

The increasing occurrence of hospital-associated infections, particularly bacteremia, caused by extensively drug-resistant (XDR) carbapenemase-producing colistin-resistant Klebsiella pneumoniae highlights a critical requirement to discover new therapeutic alternatives. Bacteriophages having host-specific bacteriolytic effects are promising alternatives for combating these pathogens. Among 12 phages isolated from public wastewater in Thailand, two phages-vB_kpnM_05 (myovirus) and vB_kpnP_08...

10.1038/s41598-024-79924-9 article EN cc-by-nc-nd Scientific Reports 2024-11-22

Reported antibiotic use in coronavirus disease 2019 (COVID-19) is far higher than the actual rate of reported bacterial co- and superinfection. A better understanding therapy COVID-19 necessary.

10.1007/s15010-021-01699-2 article EN cc-by Infection 2021-10-08
Coming Soon ...